Distinct associations of NEDD4L expression with genetic abnormalities and prognosis in acute myeloid leukemia

被引:0
|
作者
Ming-qiang Chu
Liu-chao Zhang
Qian Yuan
Ting-juan Zhang
Jing-dong Zhou
机构
[1] Affiliated People’s Hospital of Jiangsu University,Department of Hematology
[2] Affiliated People’s Hospital of Jiangsu University,Laboratory Center
[3] Qidong People’s Hospital,Medical Laboratory
[4] Affiliated People’s Hospital of Jiangsu University,Department of Oncology
来源
Cancer Cell International | / 21卷
关键词
Expression; Prognosis; Acute myeloid leukemia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Effect of Age on the Prognosis of Molecular Abnormalities in Pediatric Acute Myeloid Leukemia
    Hara, Yusuke
    Shiba, Norio
    Yamato, Genki
    Ohki, Kentaro
    Sotomatsu, Manabu
    Tabuchi, Ken
    Tomizawa, Daisuke
    Taki, Tomohiko
    Kinoshita, Akitoshi
    Kiyokawa, Nobutaka
    Arakawa, Hirokazu
    Shibuya, Masabumi
    Taga, Takashi
    Tawa, Akio
    Horibe, Keizo
    Adachi, Souichi
    Hayashi, Yasuhide
    BLOOD, 2018, 132
  • [22] Expression analysis of BECN1 in acute myeloid leukemia: association with distinct cytogenetic and molecular abnormalities
    Zare-Abdollahi, D.
    Safari, S.
    Movafagh, A.
    Ghadiani, M.
    Tabarraee, M.
    Riazi-Isfahani, S.
    Gorji, S.
    Keyvan, L.
    Gachkar, L.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (02) : 125 - 132
  • [23] ACUTE MYELOID-LEUKEMIA WITH T-LYMPHOID EXPRESSION AND DISTINCT CHROMOSOMAL-ABNORMALITIES - RESPONSE
    CUNEO, A
    CASTOLDI, G
    MICHAUX, JL
    FERRANT, A
    BOSLY, A
    BOOGAERTS, M
    DALCIN, P
    VANDENBERGHE, H
    BLOOD, 1992, 80 (05) : 1369 - 1369
  • [24] MYC Protein Expression Does Not Correlate with MYC Abnormalities but Predicts an Unfavorable Prognosis in Acute Myeloid Leukemia
    Chen, Pu
    Redd, Lucas
    Koduru, Prasad
    Dennis, Jake
    Montgomery-Goecker, Crystal
    Kumar, Kirthi
    Schmidt, Yao
    Chen, Weina
    MODERN PATHOLOGY, 2016, 29 : 339A - 339A
  • [25] MYC Protein Expression Does Not Correlate with MYC Abnormalities but Predicts an Unfavorable Prognosis in Acute Myeloid Leukemia
    Chen, Pu
    Redd, Lucas
    Koduru, Prasad
    Dennis, Jake
    Montgomery-Goecker, Crystal
    Kumar, Kirthi
    Schmidt, Yao
    Chen, Weina
    LABORATORY INVESTIGATION, 2016, 96 : 339A - 339A
  • [26] Acute Myeloid Leukemia in the Elderly Is Characterized By a Distinct Genetic Landscape
    Silva, Patricia
    Neumann, Martin
    Vosberg, Sebastian
    Schlee, Cornelia
    Isaakidis, Konstandina
    Schroeder, Michael P.
    Ortiz-Tanchez, Jutta
    Fransecky, Lars R.
    Hartung, Teresa
    Graf, Alexander
    Krebs, Stefan
    Blum, Helmut
    Ehninger, Gerhard
    Serve, Hubert
    Berdel, Wolfgang E.
    Greif, Philipp A.
    Roellig, Christoph
    Baldus, Claudia D.
    BLOOD, 2015, 126 (23)
  • [27] Aberrant Expression of MIR9 Represents a Distinct Entity with Poor Prognosis in Acute Myeloid Leukemia
    Maki, Kazuhiro
    Yamagata, Tetsuya
    Sugita, Fusako
    Nakamura, Yuka
    Sasaki, Ko
    Mitani, Kinuko
    BLOOD, 2011, 118 (21) : 1086 - 1086
  • [28] Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia
    Zhao, Yangli
    Zhang, Tingjuan
    Zhao, Yangjing
    Zhou, Jingdong
    CANCER BIOMARKERS, 2020, 29 (03) : 387 - 397
  • [29] Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities
    Vicente, C.
    Vazquez, I.
    Conchillo, A.
    Garcia-Sanchez, M. A.
    Marcotegui, N.
    Fuster, O.
    Gonzalez, M.
    Calasanz, M. J.
    Lahortiga, I.
    Odero, M. D.
    LEUKEMIA, 2012, 26 (03) : 550 - 554
  • [30] Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities
    C Vicente
    I Vazquez
    A Conchillo
    M A García-Sánchez
    N Marcotegui
    O Fuster
    M González
    M J Calasanz
    I Lahortiga
    M D Odero
    Leukemia, 2012, 26 : 550 - 554